Response inhibition in Parkinson’s disease: a meta-analysis of dopaminergic medication and disease duration effects

Parkinson’s disease is a neurodegenerative disorder involving the basal ganglia that results in a host of motor and cognitive deficits. Dopamine-replacement therapy ameliorates some of the hallmark motor symptoms of Parkinson’s disease, but whether these medications improve deficits in response inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Manza, Peter, Amandola, Matthew, Tatineni, Vivekanand, Li, Chiang-shan R., Leung, Hoi-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501877/
https://www.ncbi.nlm.nih.gov/pubmed/28702504
http://dx.doi.org/10.1038/s41531-017-0024-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501877/
https://www.ncbi.nlm.nih.gov/pubmed/28702504
http://dx.doi.org/10.1038/s41531-017-0024-2

Ejemplares similares